Skip to main content
Juan Alderuccio, MD, Hematology, Miami, FL

JuanPabloAlderuccioMD

Hematology Miami, FL

Hematologic Oncology

Associate Professor, Lymphoma Program, Division of Hematology, Sylvester Comprehensive Cancer Center

Dr. Alderuccio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alderuccio's full profile

Already have an account?

  • Office

    1475 Nw 12th Ave
    Miami, FL 33136
    Phone+1 305-243-6608
    Fax+1 305-243-4975

Summary

  • I am a board-certified Hematologist-Oncologist, and I specialize in the treatment of patients diagnosed with lymphoma. I also conduct clinical research focused on expanding the treatment repertoire for patients diagnosed with various lymphomas.

    My research efforts are geared toward improving and expanding the treatment options available for patients diagnosed with both aggressive and indolent lymphomas. In particular, I am interested in the development of novel, targeted therapies which hinges on the use of genetic sequencing technology. My current research is aimed at identifying clinical characteristics in patients with marginal zone lymphoma in an attempt to distinguish those prone to a worse outcome, as well as a higher risk for transformation to an aggressive lymphoma. Furthermore, I am also involved in studies integrating PET/CT data in the risk stratification of lymphoma patients, with the goal of developing strategies for individualize care.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2017
  • New York Medical College (Metropolitan)
    New York Medical College (Metropolitan)Residency, Internal Medicine, 2011 - 2014

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Clinical Investigator Career Development Award Lymphoma Research Foundation, 2022
  • FDA-AACR Oncology Educational Fellowship FDA and AACR, 2021-2022
  • K12 Calabresi Clinical Oncology Research Career Development Award NCI, 2019-2021

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Splenic Marginal Zone Lymphoma: A U.S Population-Based Survival Analysis (1997-2016)
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Juan Pablo Alderuccio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Omission of Staging Bone Marrow Biopsy Does Not Affect Outcomes in Patients with Stage I Extranodal Marginal Zone Lymphoma (EMZL) Treated with Radiation Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Revised-MALT-IPI: A New Predictive Model That Identifies High-Risk Patients with Extranodal Marginal Zone Lymphoma (EMZL) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip Sheet
    Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip SheetNovember 13th, 2024
  • Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition – Tip Sheet
    Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition – Tip SheetNovember 13th, 2024
  • BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce Collaboration
    BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce CollaborationMay 23rd, 2023
  • Join now to see all

Committees

  • Member, Protocol Review and Monitoring Committee 2021 - Present
  • Member, American Society of Hematology Committee on Educational Affairs

Professional Memberships

Other Languages

  • Spanish